In the past 30 years, basic research in disciplines such as cell biology and genetics has provided invaluable insights into the regulatory circuits that govern tumor onset and progression. Capitalizing on this wealth of information, molecular oncology is now revolutionizing the way we diagnose and treat cancer and offers unprecedented opportunities to improve the outlook of cancer patients on a rational basis.
The objective of the meeting is to unite eminent late-career scientists and outstanding young investigators for parallel presentations of seminal discoveries and new horizons in the fields of oncogenic signaling and cancer precision medicine.